Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Anyone else feel the same?
View:
Post by N0taP00p on Sep 06, 2024 11:17am

Anyone else feel the same?

That TLT is going to be a dollar shy and quarter late again?    I'm practicing cartwheels just in case they actually get enough money to survive and submit a BTD application in the next 3 weeks.  To stay on track they would probably need to submit the pre-BTD application about now.  If we go by their past performance, they'll probably miss it.  Will they at least communicate stats clearly to shareholder? Only a few weeks to find out.
Comment by DJDawg on Sep 06, 2024 11:20am
My only hope that things would be different this time is that any bigger investors were waiting for the Aug 22 massive warrant pile to expire. That is the only thing that is really different for this PP round. If any of those bigger investors have a few million then we are good to go till BDT and a bit beyond.
Comment by Legit62 on Sep 06, 2024 11:41am
One thing is for sure, if Roger was able to pull in some big investors we can pretty much guarantee this train will keep rolling,hoping in the 5 to 10 million range,the $250,000 a wack aint cutting it and then desparate measures to keep us afloat will happen, unless we get a partner to get us thru this fast
Comment by N0taP00p on Sep 06, 2024 12:31pm
DJD: Hope that's the case ie. bigger investors are buying into a smaller share pool at a critical point of approval. Maybe it's a good  enough ncentive. Maybe. Legit: Completely agree.  These small tranches are going to be very painful, unless all our ducks are in a row and BTD is almost a given after so much interaction with the FDA.  The data is really good and all the ...more  
Comment by Alamir1111 on Sep 06, 2024 12:41pm
I forsee a 10 billion  buy out??
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250